Elevance Health, Inc. (ELV)
| Market Cap | 71.10B |
| Revenue (ttm) | 189.25B |
| Net Income (ttm) | 5.36B |
| Shares Out | 225.18M |
| EPS (ttm) | 23.39 |
| PE Ratio | 13.50 |
| Forward PE | 10.28 |
| Dividend | $6.84 (2.17%) |
| Ex-Dividend Date | Sep 10, 2025 |
| Volume | 2,310,105 |
| Open | 309.23 |
| Previous Close | 308.48 |
| Day's Range | 307.97 - 316.50 |
| 52-Week Range | 273.71 - 544.60 |
| Beta | 0.60 |
| Analysts | Buy |
| Price Target | 399.00 (+26.36%) |
| Earnings Date | Oct 16, 2025 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for ELV stock is "Buy." The 12-month stock price target is $399.0, which is an increase of 26.36% from the latest price.
News
AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Notes
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health Inc.'s (Elevance Health) (headquartered in Indianapolis, IN) newly...
Elevance Health: Keep It Simple And Buy This Great Business At A Low Valuation
ELV stands out as an outperformer due to strong historical performance, capital returns, and a robust balance sheet. Sector tailwinds and AI-driven efficiency gains present attractive long-term opport...
Elevance Health Foundation Awards $6.5 Million to Strengthen Maternal and Infant Health Across the United States
INDIANAPOLIS--(BUSINESS WIRE)--The Elevance Health Foundation has awarded 29 new grants totaling more than $6.5 million to support maternal and infant health programs across the country. The funding w...
Top 15 High-Growth Dividend Stocks For September 2025
My Top 15 high-growth dividend stocks for September 2025 are collectively 32% undervalued and offer a 1.43% yield with 21.57% five-year dividend growth. The strategy's five-year annualized return is 1...
Elevance Health - Piggy Bank Or Headache?
Elevance and peers face earnings pressure from rising medical costs, driven by deferred care, expensive drugs, and persistent medical inflation. The segment has re-rated, and now offers good value. In...
Elevance Health loses bid to challenge US Medicare star ratings
A federal judge in Texas on Tuesday rejected Elevance Health's challenge of the U.S. government's calculation for the health insurer's star ratings for some of its government-backed Medicare plans aft...
Elevance Health and National Association of Community Health Centers Partnership Integrates Food as Medicine With Primary Care
INDIANAPOLIS--(BUSINESS WIRE)-- #ElevanceHealth--Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of Food as Medicine (FAM) progra...
3 SWANs On Sale
Our focus for today includes BMY, REXR, and ELV. The trio offers a safe 4.2% dividend yield, an A- credit rating average, and a 27% weighted discount to fair value. Bristol-Myers Squibb possesses a li...
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...
Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence
INDIANAPOLIS--(BUSINESS WIRE)--The board of directors of Elevance Health (NYSE: ELV) announced today that Steve Collis, a highly regarded global healthcare executive, will be joining the company's boa...
Elevance Health: CEO Buys As CareBridge Drives Strong Growth
On July 18, the CEO bought $2.4MM worth, after the sell-off following the last earnings call. Carelon Services is growing fast, supported by the December acquisition of CareBridge. The aging populatio...
Study Finds Digital Asthma Program Significantly Improves Symptom Control in Adults
INDIANAPOLIS--(BUSINESS WIRE)-- #DigitalHealth--Study by Elevance Health, UCI, in collaboration with Apple, highlights potential of digital health tools to reduce asthma burden in U.S. populations.
S&P 500 Gains and Losses Today: Pepsi Stock Turns Higher; Elevance Health Tumbles
Major U.S. equities indexes pushed higher Thursday as a report revealed an increase in retail sales in June, suggesting that consumer spending remains strong despite tariff concerns.
Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More
Major U.S. equities indexes were higher at midday Thursday in the wake of better-than-expected quarterly results from several major companies. The Dow, S&P 500, and Nasdaq all advanced.
Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q2 2025 Earnings Conference Call July 17, 2025 8:30 AM ET Company Participants Felicia Farr Norwood - Executive VP & President of Government Health Benefits Gail Kozi...
Elevance Stock Falls After Earnings. What It Means for UnitedHealth, Other Insurers.
The health insurer now expects 2025 earnings of just $30 a share, citing ongoing and industry-wide impact of elevated cost trends in ACA and Medicaid.
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecas...
Elevance cuts annual profit forecast on high medical costs
Elevance lowered its annual profit forecast on Thursday as it expects elevated medical costs in its government-backed plans to persist, sending its shares 7% lower in premarket trading.
Elevance Health Reports Second Quarter 2025 Results
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results. "In the second quarter, Elevance Health made meaningful progress in delivering an experience that...
Elevance Health: Much Cheaper Than UNH, Yet No Drama
The market often misinterprets price declines as value. For Elevance Health, I see a disconnect between market cap and long-term earnings potential. Health sector valuations have dropped sharply, but ...
Elevance Health: Should You Buy ELV Stock Ahead Of Its Upcoming Earnings?
Elevance Health (NYSE:ELV) is set to report its earnings on Thursday, July 17, 2025. For traders focused on events, analyzing past stock performance surrounding earnings announcements can yield valuab...
Elevance Steps In As UnitedHealth Delays — Will It Set The Tone For Insurers?
Health insurer Elevance Health Inc. ELV is scheduled to release its second quarter 2025 financial results on July 17.
Eyes On Elevance Health, Not UnitedHealth, As First To Report Earnings
For years now, UnitedHealth Group has been the first of the major health insurers to report its quarterly earnings. And Wall Street analysts and investors have looked to the healthcare giant -- which ...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options